SCHEMBL2606448

SCHEMBL2606448

COC(=O)C1CCCCC1N(C(N)=O)C1CCCCC1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.39
SLC6A2 P23975 2/20 0.37
SLC6A4 P31645 1/20 0.37
CHRM2 P08172 1/20 0.36
CHRM4 P08173 1/20 0.36
CHRM3 P20309 1/20 0.36
TAS1R3 Q7RTX0 1/20 0.34
TAS1R1 Q7RTX1 1/20 0.34
CNR2 P34972 1/20 0.34
EPHX1 P07099 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
TRPM8 Q7Z2W7 1/20 0.33
KDM4E B2RXH2 1/20 0.32
MEN1 O00255 1/20 0.32
LMNA P02545 1/20 0.32
ALOX15 P16050 1/20 0.32
ALOX12 P18054 1/20 0.32
RECQL P46063 1/20 0.32
ADAM17 P78536 1/20 0.32
KMT2A Q03164 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19085525 0.78 SLC6A2 (0.40) SLC6A2SLC6A4CHRM2CHRM4CHRM3
SCHEMBL2606468 0.75 S1PR3 (0.48) TSHREPHX1TRPM8KDM4EMEN1
SCHEMBL4093715 0.73 TAS1R3 (0.35) SLC6A2SLC6A4CHRM2CHRM4CHRM3
SCHEMBL28527891 0.73 SLC6A2 (0.50) SLC6A2SLC6A4CHRM2CHRM4CHRM3
SCHEMBL19458771 0.73 ALOX5 (0.45) TSHREPHX1TRPM8KDM4EMEN1
SCHEMBL2606404 0.73 ALOX5 (0.45) TSHREPHX1TRPM8KDM4EMEN1
SCHEMBL11234464 0.73 ALOX5 (0.45) TSHREPHX1TRPM8KDM4EMEN1
SCHEMBL2754 0.73 ALOX5 (0.45) TSHREPHX1TRPM8KDM4EMEN1
Urea SCHEMBL2807369 0.71 ALOX5 (0.43) TSHREPHX1TRPM8KDM4EMEN1
Hydrochloric Acid SCHEMBL13518199 0.71 ALOX5 (0.43) TSHREPHX1TRPM8KDM4EMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2444397-A1 Heteroaryl-ureas and their use as glucokinase activators Novo Nordisk A/S (DK) 2012-04-25 EP disclosed